Search Results 41-50 of 16399 for CLL

  1. Venetoclax (oral route) - Mayo Clinic

    Venetoclax is used alone or together with other medicines (eg, rituximab) to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) ...

  2. Hematology - Clinical trials

    A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).

  3. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  4. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

    ... Chronic Lymphocytic Leukemia (CLL). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More ...

  5. Mayo Clinic-Led Researchers Confirm Gene Variants Associated With The Most Common Adult Leukemia

    A national team of researchers led by Mayo Clinic has found that patients with chronic lymphocytic leukemia (CLL) are more likely to have similar DNA ...

  6. Leukemia Clinical Trials

    ... chronic lymphocytic leukemia (CLL) with 17p deletion. An increased rate of deaths and serious adverse events (SAEs) among participants with front-line CLL ...

  7. Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis - Mayo Clinic

    Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell ...

  8. Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas - Mayo Clinic

    Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...

  9. Ibrutinib (oral route) - Mayo Clinic

    Description. Ibrutinib is used to treat chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia (CLL)/small ...

  10. Acalabrutinib (oral route) - Mayo Clinic

    This medicine is also used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). This medicine is available only with your ...